Background: Nonrandom mating has been shown for psychiatric diagnoses, with hypothesized -but not quantified -implications for offspring liability. This national cohort study enumerated the incidence of major psychiatric disorders among the offspring of parent pairs affected with schizophrenia and/or bipolar disorder (i.e., dual-affected pairs).
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Introduction
Evidence is strong that nonrandom mating occurs for psychiatric traits (1) (2) (3) (4) as it does for features such as height, personality, and IQ, (5) (6) (7) with recent epidemiological work illustrating pervasive spousal resemblance within and across major diagnostic groups.(8) Such findings have renewed questions about the impact nonrandom mating may have on the transmission dynamics and population maintenance of psychiatric disorders. (9, 10) The double-predisposition inherent to offspring of dual-affected pairs (both at the level of genetic risk and family environment) has been hypothesized to place this group at heightened risk for psychiatric disorders (9, 11) With evidence converging on a shared genetic architecture for many major psychiatric conditions, the potential for these risks to extend beyond a parent's specific diagnoses has also been highlighted. (12, 13) If present, such risks would reflect a complex interplay of factors, with nonrandom mating introducing new -or, alternatively, augmenting known -liability pathways. (9, 10) Though theoretically consistent, study of these hypothesized risks and mechanisms has been limited. Recent simulation work (10) concluded that nonrandom mating at the scale observed in current literature -if fully attributable to assortative mating -could impact heritability and increase the population prevalence of select disorders 1.5-fold over one generation. However, such simulations carry strong assumptions and, while useful for quantifying an upper-limit, real-world assessments are needed to pinpoint true effects.
National register data have previously been leveraged to these ends, with a Danish investigation showing much higher cumulative incidences for both schizophrenia and bipolar disorder (> 25%) among the offspring of homotypic M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 4 parents (e.g., both partners having the same diagnosis) (11) , compared to offspring of single-affected or unaffected pairs. A novel attempt to extend this examination to heterotypic pairs (i.e., one parent with schizophrenia, the other bipolar disorder) was underpowered (despite national sample sizes of 2.7m) and cross-disorder outcomes were not extensively interrogated. In subsequent Danish work, Dean and colleagues surveyed a broad spectrum of cross-disorder outcomes among the offspring of more loosely defined heterotypic pairs (one parent with 'psychosis,' co-parent any alternate diagnosis). Their findings suggested heightened risks across the full range of examined conditions, (14) however, differential risks by specific parental diagnoses (e.g., dualschizophrenia versus dual-bipolar) could not be assessed.
Access to data that permits study of well-defined, homotypic (samedisorder) and heterotypic (differing disorder) pairs is critical for untangling the relationship between dual-parental psychopathology, offspring outcomes, and population disorder maintenance. The Swedish medical registers are unique in scale, offering coverage of psychiatric diagnoses for > 4.2 million parental pairs and 8.3 million offspring since records began in 1969. Using these data, the present study will consider the cumulative incidence (by age 42) of broad psychiatric conditions among the offspring of parental pairs affected with schizophrenia and/or bipolar disorder. To evaluate the impact of nonrandom mating on liability, these full-population incidences will then be used to inform heritability models, testing for variation in liability to schizophrenia and bipolar disorder among the offspring of dual versus single-affected pairs. Consistent with expectations from a polygenic model of inheritance, we hypothesize no M A N U S C R I P T A C C E P T E D ACCEPTED MANUSCRIPT 5 difference in disease heritability between the offspring of single versus dualaffected pairs.
Methods and Materials
Approval for the study was granted by the Regional Ethical Review Board in Stockholm, Sweden (reference 2013/862-31/5). All data were de-identified and collected as part of governmental health and resource tracking. Accordingly, the requirement for informed consent was waived.
Swedish National Registers
Data were linked across multiple total population registers via unique civic registration numbers (personnummer). These identifiers are assigned to all 8; 1969-1986) , ninth (ICD-9; 1987 -1996 , or tenth (ICD-10; 1997-present) revisions]. In the present study, these diagnoses have been used to define both exposure (e.g., parental diagnoses) and outcome (e.g., offspring diagnoses). The Prescribed Drug Register (PDR), which records all medications prescribed and dispensed in Sweden [Anatomical Therapeutic Chemical (ATC) Classification
System codes], was also used in select outcome definitions..
Study Population
A population-based cohort consisting of all Swedish residents alive/born 1968-2013 was generated, containing 8,343,951 index offspring from 4, 255, 196 unique parent pairs. These indexes were followed from either 1973 (the point at which the NPR achieves full psychiatric coverage) or their more recent date of birth.
Measures
Exposures
Parental exposure groups were generated, separately, for schizophrenia and bipolar disorder during the study period. Consistent with convention, (17) 
Outcomes
Offspring of all parental pairs were followed-up to check for registration of psychiatric diagnoses, including SCZ, BIP, and additional diagnoses of interest.
These disorders were grouped into categories and defined operationally, per Supplemental Table 1 . An aggregate 'any disorder' outcome was also established, reflecting diagnosis of any disorder of interest during the follow-up period. The majority of ICD codes underlying all key outcomes have been subjected to validation studies. (21, 22) 
Additional Variables
Essential covariates extracted from the TPR included parent/offspring gender and birth year of parents (used to compute parental age at birth).
Follow-Up
Offspring were followed from either 1973 or their more recent date of birth, through to the first of the following: outcome event (registered diagnosis), death, emigration, or study conclusion (December 31, 2013). This follow-up procedure was repeated anew for each disorder of interest, thus timing of the 'first' event in the incidence figures may vary within individual by examined outcome.
Statistical Analysis
Hazard Ratios
Hazard ratios (HR) for offspring outcomes were computed for each of the following exposure groups, relative to the offspring of general population indexes: offspring of homotypic parental pairs (both parents with the same diagnosis), offspring of heterotypic parental pairs (one parent with SCZ, the other BIP), and offspring of single-affected parental pairs (only one partner diagnosed). Both single-affected and heterotypic estimates were produced by parent gender. HR estimates were adjusted for the key confounders of parental age (treated categorically as decade of birth) and age at birth of each child (5- year increments from age 20).
Cumulative Incidence
Cumulative incidence estimates were subsequently generated for each disorder 
Heritability
In order to understand if the observed rates of psychiatric disorders in children of dual-affected pairs is consistent with expectations under a polygenic model, we estimated heritabilities for schizophrenia (ℎ ௌ ଶ ) and bipolar disorder (ℎ ூ ଶ ) from the HR estimates using equations provided Wray and Gottesman (23) derived from liability threshold model theory. (23) (24) (25) M A N U S C R I P T
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Results
Within-Disorder Risks
Homotypic Parents
Schizophrenia. The age-adjusted risk of SCZ among the offspring of homotypic pairs (see Table 1 ), was high relative to the general population (HR = 55.3, 95% CI = 39.9-76.7). These risks were also substantially higher than those observed in the offspring of single-affected partnerships (range= 8.4-8.8, 95% CI = 7.5-9.5;
see Table 2 ). By age 41, the expected cumulative incidence of schizophrenia in the offspring of homotypic pairs reached 18.7% (95% CI = 13.1-24.8), exceeding the incidence rates in all comparison groups (range: 0.5-4.0%; see supplement).
Bipolar Disorder. Among the offspring of offspring of homotypic BIP pairs, adjusted risk was also higher than all comparison populations (HR = 23.3, 95% CI = 17.6-30.7), including single-affected partnerships (range = 6.3-6.6, 95% CI = 5.9-6.9; see Table 2 ). Over follow-up, expected cumulative incidence of BIP in the offspring of homotypic parents reached 18.8% (95% CI = 13.6-24.3%),
representing a significant increase relative to offspring of both single-affected and general population pairs (0.9-5.5%: see Figure 1 ).
Heterotypic Parents
Among the offspring of heterotypic pairs ( Figure 2 ).
Cross-Disorder Risks Table 1 summarizes HRs for a range of psychiatric diagnoses, among the offspring of homotypic, heterotypic, and single-affected SCZ/BIP pairs.
Cumulative incidences for these broad diagnoses are presented in Supplemental Table 2 , with a selection of curves presented in Figure 2 . Disorder-specific summaries are offered below.
Cross-Disorder Risks from Homotypic Parents
Schizophrenia. Hazard ratios for all examined diagnoses were raised in the offspring of homotypic SCZ pairs (range: 2.9-11.8) relative to single-affected and general population pairs, with confidence intervals overlapping only between offspring of dual and single-affected (fathers) for anxiety disorders (Table 2) .
Similarly, the cumulative incidence for each examined outcome was significantly higher among the offspring of homotypic pairs (range = 9.6-26.8%) than among comparison populations, excepting again a slight overlap with anxiety disorders (see Supplemental Table 2 ). Supplemental Table 2 ).
Cross-Disorder Risks from Heterotypic Parents
Among the offspring of heterotypic pairs, the HRs for all examined conditions were raised, relative to the offspring of general population pairs (HR range = 3.1-6.4; see Table 2 ). Cumulative incidences were also significantly higher for these offspring, trending also-in the majority of cases -above the rates seen in the offspring of single-affected pairs (see Supplemental Table 2 ). Table 3 ), demonstrating the high HR for offspring of dual-affected parents is consistent with the HR for offspring of single-affected parents under a polygenic model of liability to risk.
Any Disorder Risks
Discussion
This national cohort study followed the psychiatric outcomes of > 8 million In keeping with the liability overlap suggested by twin and family studies, 
Non-Specificity of Diagnostic Risk from Dual-Affected Pairs
Our results accord with an emerging, polygenic picture of psychiatric liability, and are consistent with the hypothesis that a clustering of genetic risk (e.g., increased variance in disorder liability as a consequence of genetic loading from two affected parents) is expectable in the offspring of two affected parents and will drive increases in incidence. (6, 31, 32) Recent molecular work implicates common, often overlapping variants, (33) (34) (35) (36) as risk factors for a range of major psychiatric conditions and there exists a broad body of literature -from familial, genetic, and meta-analytic studies (14, 27, 37, 38 ) -attesting to the non-specificity of psychiatric risk among individuals with an affected first-degree relative.
Indeed, family history is regarded as among the strongest predictors for disorders including those examined here, with emerging work indicating a potentially stronger role for common variants in cases where a family history is present. (33, 35, 36, 39) Work in SCZ is forefront in this area, with one novel investigation signaling that case individuals with a family history of SCZ may, relative to non-family history cases, be enriched for polygenic risk linked to this and other conditions (e.g., BIP, MDD). (35) M A N U S C R I P T
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Our findings would support such a transdiagnostic risk dynamic. While hazards varied, to an expectable degree (14) , with the molecular relatedness of conditions (e.g., risks were higher for neuropsychiatric disorders than anxiety disorders), the overall portrait is one of broadly heighted liability in the offspring of dual-affected pairs. Indeed, the cumulative incidence for 'any' major psychiatric disorder was near to half for all samples -with the highest incidence observed in the offspring of heterotypic pairs in which mothers carried the bipolar diagnosis (49.87%; 41.91-59.33). At the population level, such findings suggest that, if nonrandom mating is to have an impact on the maintenance of psychiatric disorders, the pathways are unlikely to be confined to (or even primarily defined by) transmission within-disorder, but rather will integrate these contributions to cross-disorder liability -reflected, crucially, in not only homotypic but also the more numerous heterotypic pairings.
Of note, genetic modeling work has suggested that nonrandom mating could, if due to assortative mating, increase the prevalence and, potentially, heritability of rare, highly-heritable conditions (e.g., schizophrenia). (40) However, the mechanism of effect for established patterns of nonrandom mating (e.g., assortment vs. convergence) remains unclear. While high, risks are furthermore not decisive and mechanisms of balance (e.g., reduced fecundity in major psychiatric populations) have not been integrated into current transmission models. Even this is not straightforward, however, with sharply reduced fecundity suggested in some major disorders (e.g., schizophrenia), but less-so in others (e.g., major depression).(41) Work considering the degree to which risks shown in the present study are maintained in more common disorder groups (e.g., parents with major depression) will, therefore, be integral
to parsing the relevance of established nonrandom mating to cross-generational disorder maintenance. With cross-disorder mating established as common, and the current work highlighting the maintenance of risk in mixed-pairs, consideration of these dynamics will also be essential in such groups.
Strengths and Limitations
The strengths of this study rest in the large-scale, population-based register data utilized, which permitted estimation of target outcomes, including lifetime incidences and heritability, from a single data source. Limitations are those inherent to register data, including the detection bias which may result from dependence on treatment-seeking, hospital-based, largely inpatient samples -a greater concern for select outcomes in the current investigation (e.g., depression, anxiety), as the primary disorders of interest are those more likely to require inpatient management. This self-selection, along with our decision to use naturalistic samples with minimal restrictions on psychiatric comorbidity, means that our incident estimates are appropriately viewed as a minimum for all sample. It is also possible that both the partners and offspring of individuals with major psychiatric disorders are more likely to be in contact with medical services, and thus be documented in the registers -potentially inflating the relative risks seen in the present investigation.
We have made efforts to be strict in our definitions of the primary disorders of interest, requiring at least two diagnoses to minimize the impacts of misdiagnosis on results (estimates derived using single-diagnoses were similar [Supplemental Table 3] ). This conservative approach has resulted in smaller numbers for select groups, with care required when interpreting (or generalizing M A N U S C R I P T
A C C E P T E D ACCEPTED MANUSCRIPT
19 from) these rare outcomes. The validity of the heritability estimates is directly dependent on the quality of the register diagnoses, and therefore shares their limitations. Our estimates of heritability ignored contributions of shared common environment; however, we note these had previously been estimated to be small. Moreover, we note that the increased risks of disorders in children Curves represent the cumulative incidence of the titled disorder among offspring, by parental pair type (e.g., for Schizophrenia: "Gen Pop" = Offspring of general population pairs (neither parent diagnosed with schizophrenia). "Father/Mother Only" = Offspring of pairs in which only the father/mother has a schizophrenia diagnosis; "Both" = Offspring of homotypic pairs (both parents diagnosed with schizophrenia).
FIGURE 2
Curves represent the cumulative incidence of the titled disorder among offspring, by parental pair type (e.g., for Dual Schizophrenia: "Gen Pop" = Offspring of general population pairs (neither parent diagnosed with schizophrenia). "Father/Mother Only" = Offspring of pairs in which only the father/mother has a schizophrenia diagnosis; "Both" = Offspring of homotypic pairs (both parents diagnosed with schizophrenia).
FIGURE 3
Curves represent the cumulative incidence of 'any disorder' (defined as any of the defined disorders/disorder groups) among offspring, by parental pair type (e.g., for 'Mother SCZ, Father BIP': "Gen Pop" = Offspring of general population pairs (mothers no SCZ diagnosis, fathers no BIP diagnosis), "Heterotypic" = Pairs in which mothers diagnosed with SCZ, fathers BIP). 
